Source:http://linkedlifedata.com/resource/pubmed/id/11549791
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-9-10
|
pubmed:abstractText |
This paper details a UK consensus conference held in London in April 2000 to establish guidelines for the use of cyclosporin A for atopic dermatitis in children. It should be reserved for the severest refractory atopic dermatitis. In view of its potential toxicity, careful monitoring is mandatory, in particular blood pressure and renal function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1018-8665
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
203
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11549791-Child,
pubmed-meshheading:11549791-Cyclosporine,
pubmed-meshheading:11549791-Dermatitis, Atopic,
pubmed-meshheading:11549791-Dermatologic Agents,
pubmed-meshheading:11549791-Drug Monitoring,
pubmed-meshheading:11549791-Humans,
pubmed-meshheading:11549791-Immunosuppressive Agents
|
pubmed:year |
2001
|
pubmed:articleTitle |
Cyclosporin for atopic dermatitis in children.
|
pubmed:affiliation |
Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London, UK.
|
pubmed:publicationType |
Journal Article,
Guideline,
Review,
Research Support, Non-U.S. Gov't,
Practice Guideline,
Consensus Development Conference
|